Patents by Inventor Dieter Zopf

Dieter Zopf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-androgenic pyrrolidines with tumor-inhibiting action
    Patent number: 7138421
    Abstract: This invention relates to anti-androgenic N-[?-[3-[4-cyano-3-(trifluoromethyl)-phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]alkyl]-substituted pyrrolidines of general formula I, with a strongly pronounced antiproliferative profile of action; process for the production of the compounds of general formula I, pharmaceutical preparations and the use for the production of pharmaceutical agents.
    Type: Grant
    Filed: May 10, 2004
    Date of Patent: November 21, 2006
    Assignee: Schring Aktiengesellschaft
    Inventors: Arwed Cleve, Volker Schulze, Dieter Zopf, Jens Hoffmann, Andreas Reichel, Karsten Parczyk
  • Quinoline derivative, its use, production and pharmaceutical agents containing the latter
    Publication number: 20060167035
    Abstract: This invention relates to a quinoline derivative with general formula A in which R1, R2, R3, X, Y, Z and A are indicated in the description and the claims, the use of the compounds of general formula A for treating various diseases as well as the production of compounds of general formula A.
    Type: Application
    Filed: December 21, 2005
    Publication date: July 27, 2006
    Inventors: Wolfgang Schwede, Stefan Jaroch, Benjamin Bader, Roman Hillig, Antonius Ter Laak, Dieter Zopf
  • Anti-androgenic pyrrolidines with tumor-inhibiting action
    Publication number: 20050159468
    Abstract: This invention relates to anti-androgenic N-[?-[3-[4-cyano-3-(trifluoromethyl)-phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]alkyl]-substituted pyrrolidines of general formula I, with a strongly pronounced antiproliferative profile of action; process for the production of the compounds of general formula I, pharmaceutical preparations and the use for the production of pharmaceutical agents.
    Type: Application
    Filed: May 10, 2004
    Publication date: July 21, 2005
    Inventors: Arwed Cleve, Volker Schulze, Dieter Zopf, Jens Hoffmann, Andreas Reichel, Karsten Parczyk
  • Piperazine derivatives that destabilize androgen receptors
    Patent number: 6861432
    Abstract: This invention relates to new piperazine derivatives of general formula I, in which V, W, n, R, R?, i, j, Y and Z have the meaning that is indicated in the description. The compounds according to the invention are distinguished by a diazacycloalkane substituent. They have at their disposal a special action with respect to the action that destabilizes the androgen receptor and can be used, for example, for treating prostrate cancer.
    Type: Grant
    Filed: November 22, 2002
    Date of Patent: March 1, 2005
    Assignee: Schering Aktiengesellschaft
    Inventors: Arwed Cleve, Christoph Huwe, Volker Schulze, Helmut Morack, Dieter Zopf, Jens Hoffmann, Andreas Reichel
  • Piperazine derivatives that destabilize androgen receptors
    Publication number: 20040009969
    Abstract: This invention relates to new piperazine derivatives of general formula I, 1
    Type: Application
    Filed: November 22, 2002
    Publication date: January 15, 2004
    Applicant: Schering AG
    Inventors: Arwed Cleve, Christoph Huwe, Volker Schulze, Helmut Morack, Dieter Zopf, Jens Hoffmann, Andreas Reichel
  • Decreased interference redox detection system
    Patent number: 5756359
    Abstract: The present invention relates to reagents and processes for the preparation of diagnostics which use a chromogenic redox detection system and whose chromogenic redox detection system essentially remains unaffected by interference from reducing. compounds in the sample material.
    Type: Grant
    Filed: May 20, 1997
    Date of Patent: May 26, 1998
    Assignee: Behring Diagnostics GmbH
    Inventors: Klaus Habenstein, Dieter Zopf, Winfried Bursch
  • Decreased interference redox detection device
    Patent number: 5683656
    Abstract: The present invention relates to reagents and processes for the preparation of diagnostics which use a chromogenic redox detection system and whose chromogenic redox detection system essentially remains unaffected by interference from reducing compounds in the sample material.
    Type: Grant
    Filed: February 22, 1996
    Date of Patent: November 4, 1997
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Klaus Habenstein, Dieter Zopf, Winfried Bursch